Molecular pathology of thyroid tumors;Molekularpathologie von Schilddrüsentumoren

Pathologe

Volumn 31, Issue SUPPL. 2, 2010, Pages 229-233

  Schmid, K W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Differential diagnosis; Molecular pathology; Thyroid gland; Tumour

Indexed keywords

MICRORNA;

ADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; HUMAN; MEDULLARY CARCINOMA; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVIEW; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; CARCINOMA, MEDULLARY; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; MICRORNAS; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 79953237067     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1321-2     Document Type: Article

References (33)

1. Arora N, Scognamiglio T, Zhu B, Fahey TJ 3rd (2008) Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32:1237-1246
2. Bongarzone I, Butti MG, Fugazzola L et al (1997) Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics 42:252-259
3. Cheung L, Messina M, Gill A et al (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88:354-357
4. Elisei R, Cosci B, Romei C et al (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682-687
5. Franc B, Salmonière P de la, Lange F et al (2003) Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol 34:1092-1100
6. Harach HR (1997) Histogenesis of thyroid C-cell carcinoma. Curr Top Pathol 91:15-20
7. He H, Jazdzewski K, Li W, Liyanarachchi S et al (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102:19075-19080
8. Hofman V, Lassalle S, Bonnetaud C et al (2009) Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility. Virchows Arch 455:21-33
9. Karger S, Weidinger C, Krause K et al (2009) FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer 16:189-199
10. Kaserer K, Scheuba C, Neuhold N et al (2001) Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol 25:1245-1251
11. Koperek O, Scheuba C, Cherenko M et al (2008) Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology 52:623-630
12. Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103:2269-2273
13. Mulligan LM, Eng C, Healey CS et al (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6:70-74
14. Musholt PB, Musholt TJ, Morgenstern SC et al (2008) Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot. World J Surg 32:722-728
15. Nikiforova MN, Lynch RA, Biddinger PW et al (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326
16. Nikiforova MN, Nikiforov YE (2008) Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 8:83-95
17. Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones (Athens) 8:23-28
18. Saggiorato E, Rapa I, Garino F et al (2007) Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. J Mol Diagn 9:214-219
19. Schmid KW, Sheu SY, Görges R et al (2003) Tumoren der Schilddrüse. Pathologe 24:357-372
20. Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385-393
21. Schwertheim S, Sheu SY, Worm K et al (2009) Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res 41:475-481
22. Sheu SY, Schwertheim S, Worm K et al (2007) Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol 20:779-787
23. Sheu SY, Grabellus F, Schwertheim S et al (2009) Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res 41:482-487
24. Sheu SY, Grabellus F, Schwertheim S et al (2010) Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102:376-382
25. Sippel RS, Caron NR, Clark OH (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924-933
26. Sobrinho-Simões M, Máximo V, Rocha AS et al (2008) Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am 37:333-362
27. Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256-1264
28. Volante M, Rapa I, Gandhi M et al (2009) RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 94:4735-4741
29. Vriens MR, Schreinemakers JM, Suh I et al (2009) Diagnostic markers and prognostic factors in thyroid cancer. Future Oncol 5:1283-1293
30. WHO histological classification of thyroid and parathyroid tumours (2004) In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (Hrsg) World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of Endocrine Organs (2004) IARC, Lyon, S 49-123
31. Williams ED (2000) Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 8:181-183
32. Xing M (2008) Recent advances in molecular biology of thyroid cancer and their clinical implications. Otolaryngol Clin North Am 41:1135-1146
33. Xu X, Quiros RM, Gattuso P et al (2003) High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res 63:4561-4567